From The Editor
-
AI In Clinical Trials: Real Impact, Real Limits, What's Next
4/2/2026
Claude’s ClinicalTrials.gov connector changes how sponsors access trial data, but does it change outcomes? A recruitment expert weighs in on impact and what’s still missing.
-
RWE Is Ready — Decision Making For Pharmaceuticals Isn't
4/1/2026
Gorana Capkun of Merck, KGaA, Darmstadt, Germany discusses the growing role of real-world evidence in clinical trials, highlighting a gap between regulatory momentum and pharma adoption— and the challenge of turning data into better decisions.
-
AI And Clinical Trial Recruitment: Can It Fix The Funnel?
3/26/2026
Anthropic’s ClinicalTrials.gov connector gives Claude real-time access to trial data. But can conversational AI actually improve patient recruitment strategy?
-
Edge AI Is Reshaping How Clinical Trials Run
3/12/2026
Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.
-
Telehealth In Clinical Trials: What Sites And Patients Think
3/4/2026
Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
-
Telehealth In Clinical Trials: What You Need To Know
2/26/2026
Telehealth is a tool, not a trial design. Learn how televisits, ePRO, and remote monitoring fit into traditional, hybrid, and decentralized clinical trials.
-
Forget More Clinical Tech, We Need More Adoption
2/23/2026
At SCOPE Summit, Craig Lipset shared a blunt assessment of clinical trial innovation: the tools exist, regulators are engaged, and digital approaches offer clear quality advantages — yet adoption remains the industry’s biggest hurdle. From evolving FDA inspection expectations to the normalization (and lingering misconceptions) of decentralized trials, Lipset argues progress will depend less on new technology and more on scaling what already works.
-
Joe Dustin: Sites Are Driving Clinical Tech Evolution
2/20/2026
At SCOPE Summit 2026, Joe Dustin shared why clinical trial sites are emerging as the next drivers of innovation. As sites digitize operations and push back against the burden of sponsor-mandated systems, new models like “bring your own technology” and seamless digital data flow aim to reduce duplication, speed startup, and improve both coordinator and patient experiences.
-
How Salk And Sabin Helped Create The Modern Clinical Trial
2/17/2026
How Jonas Salk and Albert Sabin pioneered double-blind methodology, HeLa cell assays, and IBM data processing – innovations that became the global standard for clinical trials.
-
Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
12/9/2025
Rob Abbott, CEO of ISPOR, breaks down why HEOR timing keeps clashing with ClinOps timelines and offers practical ways to integrate value, evidence, and payer expectations much earlier in development.